New patent for Exelixis Inc drug CABOMETYX

   November 9, 2021    Comments Off on New patent for Exelixis Inc drug CABOMETYX    Posted in: Patent Added

Annual Drug Patent Expirations for CABOMETYX Cabometyx is a drug marketed by Exelixis Inc and is included in one NDA. It is available from one supplier. There are nine patents…

The post New patent for Exelixis Inc drug CABOMETYX appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog